As I see things at this point investors need to consider some simple perspectives in relation to the costs and associated matters with the radical changes EDE is introducing into the field of infrastructure.
Weigh up estimates and time frames, expectations and procedures, approvals and specifications, increased workforce and coverage, refined and diversified products, localized and international testing and trialling, increased R&D and an expanded profile and ultimately the associated ‘Risks and Rewards’ that suit your personal profile.
On that basis I am prepared to stay the course and accumulate as I can, particularly given the fact there has not been one adverse test or trial result to date, the company has detailed plans and the industry is abuzz with the reality that money is pouring into infrastructure across the globe.
A positive forecast? Yep.
Aimvho, dyor and gltah.
Add to My Watchlist
What is My Watchlist?
